Bastasa, Raquel Jean .
HRN: 28-27-52 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/16/2025
CEFUROXIME 500MG (TAB)
12/16/2025
12/16/2025
PO
500 Mg
BID
UTI Following Delivery
Checking Final Appropriateness